HR-617-116
Placed on Senate Legislative Calendar under General Orders. Calendar No. 344.
Sponsored by Ralph Norman (R-SC)
What it does
This bill would direct the Department of Energy (DOE) to create a research program using artificial intelligence and high-performance computing focused on veterans' health care. The program would develop tools to handle large, complex health data sets and help the Department of Veterans Affairs (VA) identify potential health risks among veterans. DOE would also be authorized to extend these data-analysis tools to federal agencies, universities, nonprofit research groups, and private industry.
Who benefits
U.S. military veterans, who could receive more accurate and timely identification of health risks through improved data analysis. The VA, which would gain access to advanced computing tools to manage and interpret large health data sets. Universities, nonprofit research organizations, and private companies that could partner with DOE on big-data research. DOE national laboratories, which could expand their research mission and capabilities.
Who is hurt
Private technology and data analytics firms that currently compete for VA health data contracts could face reduced business if DOE capabilities displace them. Taxpayers would bear the cost of funding a new DOE research program, though the bill does not specify an appropriation amount. Other DOE research priorities could face resource competition if the agency's budget is not expanded to accommodate the new program.
Supporters argue
Supporters argue that DOE's national laboratories already possess some of the world's most powerful supercomputers and deep expertise in handling massive, complex data sets — capabilities the VA currently lacks. Veterans' health records represent an enormous and underutilized data resource; applying AI and high-performance computing to that data could reveal patterns in conditions like toxic exposure, traumatic brain injury, and post-traumatic stress that smaller-scale analysis would miss. By leveraging existing federal infrastructure rather than building new systems from scratch, the program would deliver better health outcomes for veterans at relatively low marginal cost. Supporters also note that the bill's broader authorization — allowing DOE tools to serve other agencies, universities, and nonprofits — multiplies the return on any federal spending by spreading advanced capabilities across the research community.
Opponents argue
Opponents argue that directing DOE — an agency whose core mission is energy research and nuclear security — into veterans' health care represents a mission stretch that could dilute focus and produce duplicative bureaucracy. The VA and the Department of Health and Human Services already have existing health data infrastructure, and critics contend that funding should strengthen those agencies rather than create a parallel program at DOE. Opponents also raise data privacy concerns: centralizing sensitive veterans' health records within DOE's computing systems introduces new cybersecurity risks and potential Fourth Amendment questions about how personal medical data is stored, accessed, and shared across federal agencies and private-sector partners. Finally, because the bill does not specify a funding level, critics warn it could become an open-ended spending commitment with limited congressional oversight over actual costs.
Constitutional context
The bill implicates the Fourth Amendment's protection against unreasonable searches and seizures as applied to digital records — particularly relevant after Carpenter v. United States (2018), which held that individuals retain a privacy interest in detailed digital data held by third parties. Aggregating veterans' personal health data across federal systems raises questions about consent, access controls, and data-sharing limits. The Commerce Clause and the Intellectual Property Clause are relevant to DOE's authority to partner with private industry and universities on AI tool development. The Spending Clause governs any grants or cooperative agreements DOE would issue. Because the bill expands an executive agency's research mandate, it also touches on separation of powers and the post-Loper Bright framework, under which courts — not agencies — independently determine the scope of statutory authority.
Checks and balances
The bill grants new discretionary authority to the executive branch — specifically DOE — to establish and direct a research program and to enter into partnerships with outside entities. Congress retains the power of the purse, as any actual spending would require a separate appropriation. The VA's role is as a beneficiary and data partner rather than a co-administrator, keeping primary program control within DOE. No new independent agency or adjudicatory body is created.
Historical precedent
The 21st Century Cures Act (2016) similarly directed federal agencies to share health data and apply advanced computing to medical research. The BRAIN Initiative and the Cancer Moonshot also established cross-agency research programs using federal computing infrastructure for large-scale health data analysis.